Author

D. Bergman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. T. Pearson· 1 shared E. Dollinger· 1 shared E. Trujillo· 1 shared P. Zhou· 1 shared Q. Nie· 1 shared R. F. Sweis· 1 shared S. Atwood· 1 shared T. L. Jackson· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. T. Pearson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mathematical Model Predicts Tumor Control Patterns Induced by Fast and Slow CTL Killing Mechanisms

Y. Wang, D. Bergman, E. Trujillo, A. T. Pearson, R. F. Sweis, T. L. Jackson

The paper constructs a mathematical model to predict tumor control patterns based on CTL killing mechanisms and evaluates therapeutic outcomes under immune checkpoint blockade.

bioRxiv · Jul 19, 2023 · PreprintCancer Biology

Divergent resistance mechanisms to immunotherapy explains response in different skin cancers.

E. Dollinger, D. Bergman, P. Zhou, S. Atwood, Q. Nie

This study identifies divergent immune resistance mechanisms in melanoma and basal cell carcinoma that explain differential responses to checkpoint immunotherapy.

bioRxiv · Sep 15, 2020Cancer Biology